Sage Therapeutics, Inc was founded in 2010 and is headquartered in Cambridge, Massachusetts, the US. Sage is a biopharmaceutical company committed to developing and commercializing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the US with its two offices in Cambridge and Raleigh. As of February 16, 2022, the company employed 471 full-time employees, including 253 in research and development and 218 in selling, general, and administrative, and no part-time employees.
| Company Name | Sage Therapeutics, Inc. |
|---|---|
| Industry | Biotech company |
| HQ Address | Cambridge, MA, US |
| Revenue | $6,308 Thousand [2021] |
| Employee Size | 471 |
| Company Type | Public |
| Fiscal Year-End | December 31st |
| Website | www.sagerx.com |
| Subsidiaries | Sage Securities Corporation, Sage (Bermuda) Ltd., Sage Therapeutics Limited, Sage Therapeutics GmbH, Sage Therapeutics GmbH (Germany) |
| Locations | The company has two office locations, US - Cambridge, Massachusetts and US - Raleigh, North Carolina |
| Competitors | Elicio Therapeutics, Scholar Rock, and C4 Therapeutics |
| Recognition & Awards | Top Places to Work 2018 and 2019 |
Access Company's Structure and Understand its Departments
Get Access to Company's Performance and Make Informed Decisions
Get Key Executives Contact to Enhance your Sales Strategy
Understand Company's Partners and Identify Potential Areas for Collaboration
Identify Company's Key Rivals for Competitive Edge
Gain Insight into Technology Partners and Access Exclusive Information on Key Tech Partners
Explore Customer Review to Understand its Service and Pinpoints
Analyse Company Strategies to Gain Market Insights and Stay Ahead of Your Competitors